Adam O. Michel

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Induction and characterization of pancreatic cancer in a transgenic pig model”.

Induction and characterization of pancreatic cancer in a transgenic pig model

PLoS ONE(2020)10.1371/journal.pone.0239391

N/A

0DataRank · unranked

37 citations

Fuad Nurili, Achiude Bendet, Christopher Cheleuitte-Nieves, Olca Baştürk, Gökçe Aşkan +11 more

Transarterial Embolization of Liver Cancer in a Transgenic Pig Model

Journal of Vascular and Interventional Radiology(2021)10.1016/j.jvir.2020.09.011

N/A

0DataRank · unranked

45 citations

Sébastien Monette, Adam O. Michel, Achiude Bendet, Olca Baştürk, Gokce Askan +10 more

Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer

Communications Biology(2021)10.1038/s42003-021-02773-z

N/A

0DataRank · unranked

16 citations

Sadna Budhu, Kelly Fitzgerald, Rachel Giese, Adam O. Michel, Aliya Holland +7 more

WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC

Cell Reports(2022)10.1016/j.celrep.2022.110814

N/A

0DataRank · unranked

134 citations

Rebecca Caeser, Shweta S. Chavan, Yingqian A. Zhan, Andrew Chow, Parvathy Manoj +15 more

Supplementary Materials and Methods, Supplementary 1-7 and Supplementary Table 1. from ERK Inhibition Improves Anti–PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma

(2023)10.1158/1535-7163.22520551

N/A

0DataRank · unranked

0 citations

Kyeara N. Mack, Veronica L. Nagle, Mike Cornejo, Adam O. Michel, Ian L. Fox +5 more

Supplementary Materials and Methods, Supplementary 1-7 and Supplementary Table 1. from ERK Inhibition Improves Anti–PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma

Figshare(2023)10.1158/1535-7163.22520551.v1

N/A

0DataRank · unranked

0 citations

Kyeara N. Mack, Veronica L. Nagle, Mike Cornejo, Adam O. Michel, Ian L. Fox +5 more